Horizon Pharma reported $397.56M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.3B 174M
Aerie Pharmaceuticals AERI:US USD 33.88M 5.73M
ALKERMES ALKS:US USD 152.78M 2.4M
Amgen AMGN:US USD 1.29B 40M
AstraZeneca AZN:LN USD 3.35B 280M
Bristol Myers Squibb BMY:US USD 1.93B 147M
Cara Therapeutics CARA:US USD 6.88M 658K
Coherus Biosciences CHRS:US USD 44.83M 6.44M
Eli Lilly And LLY:US USD 1.61B 10.9M
Endo International Ordinary Shares ENDP:US USD 192.46M 10.92M
Horizon Pharma HZNP:US USD 397.56M 658K
JAZZ PHA JAZZ:US USD 317.68M 7.99M
Merk MRK:US USD 2.47B 13M
Novartis NOVN:VX USD 3.4B 185M
Pacira Pharmaceuticals PCRX:US USD 61.28M 3.72M
Perrigo Ordinary Shares PRGO:US USD 281M 57.1M
Pfizer PFE:US USD 3.54B 345M
Prestige Brands PBH:US USD 70.26M 3.59M
Revance Therapeutics RVNC:US USD 64.09M 17.91M
Supernus Pharmaceuticals SUPN:US USD 224.63M 124.15M
Takeda 4502:JP JPY 248.73B 17.25B
Teva Pharmaceutical Industries TEVA:US USD 777M 72M
Valeant Pharmaceuticals VRX:CN USD 661M 15M
Xeris Pharmaceuticals Inc XERS:US USD 34.49M 1.51M
Zoetis ZTS:US USD 501M 28M